Reqorsa® Immunogene Therapy May be a Potential Therapy for ALK-Positive Lung Cancer REQORSA has Anti-Tumor Mechanisms that Target and Disrupt the Metabolism of Cancer Cells NPRL2 Gene Therapy...

A total of 29 abstracts, including three late-breaking presentations, demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing science across a spectrum of immune-mediated...

New data from Futurum1 suggests that the mainframe skills pool is growing, with 65 percent of university leaders surveyed reporting more skilled mainframe talent available today as compared to the...

The TriZetto platform, powered by Azure OpenAI Service, will help payers and providers reduce hidden costs and enable better patient outcomes for millions of Americans. TEANECK, N.J., March 6,...

Quantic ECI, Quantic Ohmega Ticer, Quantic PMI and Quantic TRM to showcase RF and microwave technology solutions in Booth #1438 EAST PROVIDENCE, R.I., March 6, 2024 /PRNewswire/ -- Quantic®...

Native Forward Scholars Fund is the first Native organization to receive the honor in the award's 24-year history. ALBUQUERQUE, N.M., March 6, 2024 /PRNewswire/ -- Native Forward Scholars Fund has...

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that it will present data from its...

Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV), today announced the upcoming presentation of two...

Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Barclays 26th Annual Global Healthcare Conference on Wednesday,...

Koya Medical, today announces topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective multi-center, randomized cross-over study comparing lower extremity lymphedema treatment...